1. Home
  2. SVRA vs IMOS Comparison

SVRA vs IMOS Comparison

Compare SVRA & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • IMOS
  • Stock Information
  • Founded
  • SVRA 2007
  • IMOS 1997
  • Country
  • SVRA United States
  • IMOS Taiwan
  • Employees
  • SVRA N/A
  • IMOS N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • IMOS Semiconductors
  • Sector
  • SVRA Health Care
  • IMOS Technology
  • Exchange
  • SVRA Nasdaq
  • IMOS Nasdaq
  • Market Cap
  • SVRA 528.3M
  • IMOS 551.9M
  • IPO Year
  • SVRA N/A
  • IMOS N/A
  • Fundamental
  • Price
  • SVRA $2.06
  • IMOS $18.59
  • Analyst Decision
  • SVRA Buy
  • IMOS
  • Analyst Count
  • SVRA 7
  • IMOS 0
  • Target Price
  • SVRA $7.57
  • IMOS N/A
  • AVG Volume (30 Days)
  • SVRA 2.5M
  • IMOS 14.4K
  • Earning Date
  • SVRA 08-11-2025
  • IMOS 08-12-2025
  • Dividend Yield
  • SVRA N/A
  • IMOS 3.30%
  • EPS Growth
  • SVRA N/A
  • IMOS N/A
  • EPS
  • SVRA N/A
  • IMOS 0.05
  • Revenue
  • SVRA N/A
  • IMOS $685,506,006.00
  • Revenue This Year
  • SVRA N/A
  • IMOS N/A
  • Revenue Next Year
  • SVRA N/A
  • IMOS $2.21
  • P/E Ratio
  • SVRA N/A
  • IMOS $19.47
  • Revenue Growth
  • SVRA N/A
  • IMOS 2.89
  • 52 Week Low
  • SVRA $1.89
  • IMOS $12.78
  • 52 Week High
  • SVRA $5.11
  • IMOS $27.80
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 34.43
  • IMOS 46.30
  • Support Level
  • SVRA $2.13
  • IMOS $19.25
  • Resistance Level
  • SVRA $2.49
  • IMOS $19.78
  • Average True Range (ATR)
  • SVRA 0.15
  • IMOS 0.58
  • MACD
  • SVRA -0.01
  • IMOS -0.12
  • Stochastic Oscillator
  • SVRA 8.41
  • IMOS 18.70

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

Share on Social Networks: